Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Net Margin (2010 - 2011)

Updated

Mosaic ImmunoEngineering's Net Margin came in at -2110.83% for Q2 2012, down 50.33 percentage points from -2060.50% a year earlier and down 1320.15 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Net Margin (2010 - 2011) Analysis & Trends

Over the trailing twelve months to Nov 30, 2011, Mosaic ImmunoEngineering reported Net Margin of -2889.54%.

  • The Q2 2012 figure represents the lowest quarterly Net Margin since Q1 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 -2,110.83%
Aug 31, 2011 -790.68%
Nov 30, 2010 -2,060.50%
Aug 31, 2010 -2,126.84%
API Access

Mosaic ImmunoEngineering Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CPMV&period=max&api_key=YOUR_API_KEY